Bleeding and Clotting Disorders
Protocol:GENA-25
Condition or Disease: Hemophilia A
Study Type: Observational
Status: Open for enrollment
Study Title: PRactical utilization of Octapharma FVIII Concentrates in Previously Untreated and Minimally Treated Haemophilia A Patients Entering Routine Clinical Treatment (with Nuwiq, Octanate or Wilate) ‰ÛÒ A Real- World Efficacy and Safety Observational Study
Principal I investigator: Joseph Lasky III, MD
More Info: //clinicaltrials.gov/ct2/show/NCT03695978
